Triazolam: Side Effects, Uses & Monitoring
Triazolam Tablets are indicated for the short-term treatment of insomnia (generally 7 to 10 days).
- Data source
- FDA labeling via NIH DailyMed (label 73db8a0e…)
- Label version
- current
- Last reviewed
- 2026
Reported adverse reactions
Reactions listed in current FDA labeling, with the highest frequency reported across summarized placebo-controlled trials.
| Adverse reaction (as reported in labeling) | Reported frequency* |
|---|---|
| Drowsiness | 14% |
| Wbc/hpf | 11.7% |
| Eosinophil count | 10.2% |
| Headache | 9.7% |
| Dizziness | 7.8% |
| Sgot | 5.3% |
| Nervousness | 5.2% |
| Light-headedness | 4.9% |
| Coordination disorders/ataxia | 4.6% |
| Nausea/vomiting | 4.6% |
| Monocyte count | 4.4% |
| Lymphocyte count | 4% |
| Creatinine | 3.6% |
| Neutrophil count | 3.3% |
| Rbc/hpf | 2.9% |
| Alkaline phosphatase | 2.6% |
| Total wbc count | 2.1% |
| Basophil count | 2.1% |
| Bilirubin | 1.5% |
| Albumin | 1.1% |
*Highest percentage reported for the active moiety across placebo-controlled trial tables in current FDA labeling. Values reflect trial reporting, not your individual risk.
Labeled uses (from FDA prescribing information)
Triazolam Tablets are indicated for the short-term treatment of insomnia (generally 7 to 10 days). Use for more than 2 to 3 weeks requires complete reevaluation of the patient (see WARNINGS ). Prescriptions for triazolam should be written for short-term use (7 to 10 days) and it should not be prescribed in quantities exceeding a 1-month supply.
Conditions associated with Triazolam in labeling
Frequently Asked Questions
What is Triazolam used for?
FDA labeling lists the approved uses shown above under "Labeled uses." This summary is informational; only a qualified prescriber can determine whether a medication is appropriate for you.
What are the most commonly reported side effects of Triazolam?
The table above shows adverse reactions and the highest frequencies reported in placebo-controlled trials summarized in current FDA labeling for Triazolam. Individual risk varies.
Does Triazolam require lab monitoring?
Monitoring needs vary. Ask your healthcare provider whether any lab tests apply while taking Triazolam.
Where does this information come from?
All clinical facts on this page were extracted from the current FDA-registered product labeling for this ingredient, published by manufacturers through NIH DailyMed. See the source link below.
Medical disclaimer: Educational content extracted from public FDA labeling. Not medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.